CoChat

Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade

Cremers, Thomas I F H, Giorgetti, Marco, Bosker, Fokko J, Hogg, Sandra, Arnt, Jørn, Mørk, Arne, Honig, Gerard, Bøgesø, Klaus-Peter, Westerink, Ben H C, den Boer, Hans, Wikstrom, Håkan V, Tecott, Laurence H · 2004 · Neuropsychopharmacology

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

The enhancement of central serotonin system function underlies the therapeutic effects of selective serotonin reuptake inhibitors (SSRIs), which have become the most commonly used class of antidepressant agents. However, many individuals experience depressive episodes that are resistant to SSRI treatment. Homeostatic mechanisms that limit the extent to which SSRIs enhance serotonergic neurotransmission have been implicated in this phenomenon. Here, we report a novel strategy for enhancing the efficacy of SSRIs. Using in vivo microdialysis methods in rats, the nonselective 5-HT2 receptor antagonist ketanserin was observed to produce a robust augmentation of citalopram-, fluoxetine-, and sertraline-induced elevations of hippocampal extracellular serotonin levels. Similar effects were also observed in cortex. The potentiation of SSRI-induced increases in hippocampal serotonin levels was reproduced by the 5-HT(2C) receptor-selective antagonists SB 242084 and RS 102221, but not by the 5-HT(2A) receptor-selective antagonist MDL 100 907. Although 5-HT(2C) receptor antagonists augmented the actions of SSRIs, they had no effect on extracellular serotonin levels or tail suspension responses when administered alone. These results were in strong accord with independent findings using a line of 5-HT(2C) receptor-null mutant mice. Although this mutation did not affect baseline extracellular serotonin levels or tail suspension test (TST) behavior, it enhanced fluoxetine effects on serotonin…

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300474

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Cited by

See all 172

Metadata

Authors
Cremers, T. I. F. H., Giorgetti, M., Bosker, F. J., Hogg, S., Arnt, J., Mørk, A., Honig, G., Bøgesø, K.-P., Westerink, B. H. C., den Boer, H., Wikstrom, H. V., & Tecott, L. H.
Affiliations
  • University of Groningen (NL)
  • University of California, San Francisco (US)
  • University Medical Center Groningen (NL)
  • Lundbeck (Denmark) (DK)
Corresponding author
  • Cremers, Thomas I F H
  • Tecott, Laurence H
Venue
Neuropsychopharmacology
Published
2004-05-12
Volume
29
Issue
10
Pages
1782-1789
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2124373758
Cited by
157
References
41
Citations by year
2025: 3 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 10 · 2020: 6 · 2019: 1 · 2018: 6 · 2017: 5 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 8 · 2012: 5
FWCI
5.39
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
5-HT2C receptor, serotonin reuptake inhibitors, ketanserin, SB242084, fluoxetine, citalopram, sertraline, depression, antidepressant resistance, tail suspension test, immobility
MeSH terms
Animals, Brain Chemistry, Ketanserin, Male, Synaptic Transmission, Serotonin, Serotonin Antagonists, Rats, Wistar, Selective Serotonin Reuptake Inhibitors, Microdialysis, Hindlimb Suspension, Receptor, Serotonin, 5-HT2C, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade. https://app.cochat.ai/papers/10.1038/sj.npp.1300474
The paper
Cremers, T. I. F. H., Giorgetti, M., Bosker, F. J., Hogg, S., Arnt, J., Mørk, A., Honig, G., Bøgesø, K.-P., Westerink, B. H. C., den Boer, H., Wikstrom, H. V., & Tecott, L. H. (2004). Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1300474

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.